Original Research
Published on 02 Jul 2019
Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2019.01493
- 7,973 views
- 16 citations
